![Erick DeVinney](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 11 M $ al 30/06/2026
Mr. Erick W.
DeVinney is a Chief Innovation Officer at Axogen, Inc. He is on the Board of Directors at Global Nerve Foundation.
Mr. DeVinney was previously employed as a Director-Clinical & Translational Sciences by Axogen Corp., a Manager-Clinical Operations by Angiotech Pharmaceuticals, Inc., a Principal by Medical College of Virginia, and a Principal by National Clinical Research Centers, Inc. He received his undergraduate degree from Virginia Commonwealth University.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
AXOGEN, INC. 0,45 % | 01/04/2026 | 237.781 ( 0,45 % ) | 11 M $ | 30/06/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| AXOGEN, INC. | Corporate Officer/Principal | 04/01/2024 |
| Empresas | Cargo | Fin |
|---|---|---|
AxoGen Corp.
 AxoGen Corp. BiotechnologyHealth Technology Develops peripheral nerve grafting and regeneration technologies | Director Técnico/Científico/I+D | 01/01/2014 |
Angiotech Pharmaceuticals, Inc.
 Angiotech Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Manufactures medical devices and pharmaceuticals for oncology, wound closure and ophthalmology | Director Técnico/Científico/I+D | 01/01/2007 |
National Clinical Research Centers, Inc.
 National Clinical Research Centers, Inc. Miscellaneous Commercial ServicesCommercial Services Clinical trials management; pharmaceutical | Corporate Officer/Principal | - |
Medical College of Virginia
 Medical College of Virginia Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 6 |
|---|---|
Angiotech Pharmaceuticals, Inc.
Angiotech Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Manufactures medical devices and pharmaceuticals for oncology, wound closure and ophthalmology | Health Technology |
National Clinical Research Centers, Inc.
National Clinical Research Centers, Inc. Miscellaneous Commercial ServicesCommercial Services Clinical trials management; pharmaceutical | Commercial Services |
Virginia Commonwealth University
 Virginia Commonwealth University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Medical College of Virginia
Medical College of Virginia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AxoGen Corp.
AxoGen Corp. BiotechnologyHealth Technology Develops peripheral nerve grafting and regeneration technologies | Health Technology |
Axogen, Inc.
 Axogen, Inc. Medical SpecialtiesHealth Technology Provides products and technologies for peripheral nerve reconstruction and regeneration | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
